DG-041 (1.78 mg/kg for intravenous or 9.62 mg/kg for oral) has t1/2 of 2.7 hours, 4.06 hours and Cmax of 9.46 μM, 2.74 μM for intravenous and oral administration, respectively. DG-041 has CL of 1250 mL/h/kg for intravenous[1].
| Animal Model: | Male SpragueDawley rat[1] |
| Dosage: | 1.78 mg/kg (intravenous) or 9.62 mg/kg (oral) |
| Administration: |
Intravenous or oral |
| Result: | Had t1/2 of 2.7 hours, 4.06 hours and Cmax of 9.46 μM, 2.74 μM for intravenous and oral administration, respectively.
|